Using the BODY-Q to develop a prospective cohort of patients undergoing bariatric and body contouring surgery: A study protocol.
Annewiek GriftClaire de VriesValerie MonpellierDennis J S MakarawungChristel de RaaffLeontien M G NijlandAebele Mink van der MolenRene WiezerBart van WagensveldRuben van VeenSteve de CastroJoyce FlorissonMaarten HoogbergenPublished in: Clinical obesity (2022)
The BODY-Q is a patient-reported outcome measure designed to measure health-related quality of life, satisfaction with appearance and experience with healthcare in patients with obesity who undergo bariatric surgery and/or body contouring surgery after massive weight loss. The aim of this study is to collect long term PRO-data from patients living with obesity undergoing bariatric surgery, comparing patient undergoing or not undergoing body contouring surgery. This study will be a multicentre, prospective longitudinal cohort study with participation of three bariatric medical centres in the Netherlands. The BODY-Q will be used to measure the satisfaction with appearance and HRQL. Patients undergoing bariatric surgery, age >18 years and <65 years and who are able to read and understand Dutch can be included. All bariatric procedures are eligible for inclusion. Administration of the questionnaires will be done preoperatively for bariatric and body contouring surgery as well as at 3, 12, 24, 36, 48 and 60 months post-operatively. Patient-reported outcomes measurements are becoming more important with the shift to patient-centred healthcare. The collected longitudinal data can be helpful in determining the effectiveness and value of bariatric and body contouring surgery from the patient's perspective, and can contribute to patient tailored postoperative care.
Keyphrases
- weight loss
- bariatric surgery
- patient reported outcomes
- roux en y gastric bypass
- healthcare
- minimally invasive
- gastric bypass
- patients undergoing
- obese patients
- coronary artery bypass
- study protocol
- glycemic control
- case report
- weight gain
- randomized controlled trial
- type diabetes
- metabolic syndrome
- systematic review
- newly diagnosed
- coronary artery disease
- end stage renal disease
- chronic kidney disease
- palliative care
- prognostic factors
- big data
- open label
- anti inflammatory
- affordable care act
- atrial fibrillation
- pain management